How to overcome retinal neuropathy: The fight against angiogenesisrelated blindness

Archives of Pharmacal Research

Volumn 33, Issue 10, 2010, Pages 1557-1565

  Jo, Dong Hyun ^a   Kim, Jin Hyoung ^a   Kim, Jeong Hun ^a  

^a Seoul National University   (South Korea)

Author keywords

Age related macular degeneration; Angiogenesis related blindness; Diabetic retinopathy; Retinoblastoma; Retinopathy of prematurity

Indexed keywords

AGN 211745; ANECORTAVE; BEVACIZUMAB; BEVASIRANIB; CANAKINUMAB; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INFLIXIMAB; INTEGRIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OMEGA 3 FATTY ACID; PAZOPANIB; PEGAPTANIB; PF 04523655; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; RANIBIZUMAB; SIRNA 027; SMALL INTERFERING RNA; SOMATOMEDIN C; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VATALANIB; VERY LATE ACTIVATION ANTIGEN 5; VOLOCIXIMAB;

ANGIOGENESIS; BLINDNESS; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CHEMOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CRYOTHERAPY; DIABETIC RETINOPATHY; ENUCLEATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTHERMIC THERAPY; INFLAMMATION; INTRACELLULAR SIGNALING; LASER; LASER COAGULATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHY; PATHOGENESIS; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINA NERVE CELL; RETINOBLASTOMA; RETINOPATHY; RETROLENTAL FIBROPLASIA; REVIEW; RNA INTERFERENCE; SCLERA BUCKLING PROCEDURE; SMOKING; SUBRETINAL NEOVASCULARIZATION; SYSTEMIC THERAPY; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE;

ADULT; ANIMALS; BLINDNESS; BLOOD-RETINAL BARRIER; DIABETIC RETINOPATHY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MACULAR DEGENERATION; RETINAL NEOPLASMS; RETINAL NEOVASCULARIZATION; RETINAL NEURONS; RETINAL VESSELS; RETINOBLASTOMA; RETINOPATHY OF PREMATURITY;

EID: 78449234722     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-1007-6     Document Type: Review

References (80)

1. S. F. Abcouwer S. Shanmugam P. F. Gomez S. Shushanov A. J. Barber K. F. Lanoue P. G. Quinn M. Kester T. W. Gardner 2008 Effect of IL-1beta on survival and energy metabolism of R28 and RGC-5 retinal neurons Invest. Ophthalmol. Vis. Sci. 49 5581 5592 10.1167/iovs.07-1032 19037001
2. D. H. Abramson A. C. Schefler 2004 Update on retinoblastoma Retina 24 828 848 10.1097/00006982-200412000-00002 15579980
3. D. Abran D. R. Varma S. Chemtob 1995 Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides Am. J. Physiol. 268 H628 H632 1:CAS:528:DyaK2MXktFantbs%3D 7864188
4. L. P. Aiello R. L. Avery P. G. Arrigg B. A. Keyt H. D. Jampel S. T. Shah L. R. Pasquale H. Thieme M. A. Iwamoto J. E. Park 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N. Engl. J. Med. 331 1480 1487 1:STN:280: DyaK2M%2FlvFamsA%3D%3D 10.1056/NEJM199412013312203 7526212
5. J. Beutel M. Rudolf S. Grisanti 2009 Current and future therapies for age-related macular degeneration Expert Opin. Emerg. Drugs 14 341 362 1:CAS:528:DC%2BD1MXnt1Shsrs%3D 10.1517/14728210902824141 19392638
6. N. M. Bressler 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2 Arch. Ophthalmol. 119 198 207 1:CAS:528:DC%2BD3MXhsVCkurs%3D 11176980
7. D. M. Brown P. K. Kaiser M. Michels G. Soubrane J. S. Heier R. Y. Kim J. P. Sy S. Schneider 2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration N. Engl. J. Med. 355 1432 1444 1:CAS:528:DC%2BD28XhtVGgtrrI 10.1056/NEJMoa062655 17021319
8. P. Carmeliet L. Moons A. Luttun V. Vincenti V. Compernolle M. De Mol Y. Wu F. Bono L. Devy H. Beck D. Scholz T. Acker T. Dipalma M. Dewerchin A. Noel I. Stalmans A. Barra S. Blacher T. Vandendriessche A. Ponten U. Eriksson K. H. Plate J. M. Foidart W. Schaper D. S. Charnock-jones D. J. Hicklin J. M. Herbert D. Collen M. G. Persico 2001 Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat. Med. 7 575 583 1:CAS:528:DC%2BD3MXjsVakurc%3D 10.1038/87904 11329059
9. J. Chen L. E. Smith 2007 Retinopathy of prematurity Angiogenesis 10 133 140 10.1007/s10456-007-9066-0 17332988
10. K. M. Connor J. P. Sangiovanni C. Lofqvist C. M. Aderman J. Chen A. Higuchi S. Hong E. A. Pravda S. Majchrzak D. Carper A. Hellstrom J. X. Kang E. Y. Chew N. Jr. Salem C. N. Serhan L. E. Smith 2007 Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis Nat. Med. 13 868 873 1:CAS:528:DC%2BD2sXnsFWmtrw%3D 10.1038/nm1591 17589522
11. J. G. Cunha-Vaz 1976 The blood-retinal barriers Doc. Ophthalmol. 41 287 327 1:STN:280:DyaE2s%2FptVKhuw%3D%3D 10.1007/BF00146764 1009819
12. J. A. Davidson T. A. Ciulla J. B. Mcgill K. A. Kles P. W. Anderson 2007 How the diabetic eye loses vision Endocrine 32 107 116 1:CAS:528: DC%2BD2sXhsVertr7M 10.1007/s12020-007-0040-9 17992608
13. P. T. De Jong 2006 Age-related macular degeneration N. Engl. J. Med. 355 1474 1485 10.1056/NEJMra062326 17021323
14. J. A. Dixon S. C. Oliver J. L. Olson N. Mandava 2009 VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration Expert Opin. Investig. Drugs 18 1573 1580 1:CAS:528:DC%2BD1MXhtFCisLbP 10.1517/ 13543780903201684 19694600
15. J. Doukas S. Mahesh N. Umeda S. Kachi H. Akiyama K. Yokoi J. Cao Z. Chen L. Dellamary B. Tam A. Racanelli-layton J. Hood M. Martin G. Noronha R. Soll P. A. Campochiaro 2008 Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema J. Cell. Physiol. 216 29 37 1:CAS:528:DC%2BD1cXnt1eks78%3D 10.1002/jcp.21426 18330892
16. A. O. Edwards R. Ritter 3rd K. J. Abel A. Manning C. Panhuysen L. A. Farrer 2005 Complement factor H polymorphism and age-related macular degeneration Science 308 421 424 1:CAS:528:DC%2BD2MXjtFOntLw%3D 10.1126/science.1110189 15761121
17. A. B. El-Remessy G. Abou-Mohamed R. W. Caldwell R. B. Caldwell 2003 High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation Invest. Ophthalmol. Vis. Sci. 44 3135 3143 10.1167/iovs.02-1022 12824263
18. F. L. Ferris 3rd S. L. Fine L. Hyman 1984 Age-related macular degeneration and blindness due to neovascular maculopathy Arch. Ophthalmol. 102 1640 1642 6208888
19. J. Folkman 2006 Angiogenesis Annu. Rev. Med. 57 1 18 1:CAS:528: DC%2BD28Xis1Cksrg%3D 10.1146/annurev.med.57.121304.131306 16409133
20. R. N. Frank 2004 Diabetic retinopathy N. Engl. J. Med. 350 48 58 1:CAS:528:DC%2BD2cXhtFGgug%3D%3D 10.1056/NEJMra021678 14702427
21. D. S. Friedman B. J. O'Colmain B. Munoz S. C. Tomany C. Mccarty P. T. De Jong B. Nemesure P. Mitchell J. Kempen 2004 Prevalence of age-related macular degeneration in the United States Arch. Ophthalmol. 122 564 572 10.1001/archopht.122.7.1019 15078675
22. H. Funatsu H. Yamashita H. Noma T. Mimura T. Yamashita S. Hori 2002 Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema Am. J. Ophthalmol. 133 70 77 1:CAS:528:DC%2BD38XisFWh 10.1016/S0002-9394(01)01269-7 11755841
23. R. F. Gariano T. W. Gardner 2005 Retinal angiogenesis in development and disease Nature 438 960 966 1:CAS:528:DC%2BD2MXhtlSksrnP 10.1038/nature04482 16355161
24. K. M. Gehrs D. H. Anderson L. V. Johnson G. S. Hageman 2006 Age-related macular degeneration-emerging pathogenetic and therapeutic concepts Ann. Med. 38 450 471 10.1080/07853890600946724 17101537
25. C. Gilbert J. Rahi M. Eckstein J. O'sullivan A. Foster 1997 Retinopathy of prematurity in middle-income countries Lancet 350 12 14 1:STN:280: DyaK2szmtVOmsg%3D%3D 10.1016/S0140-6736(97)01107-0 9217713
26. W. V. Good R. J. Hardy V. Dobson E. A. Palmer D. L. Phelps M. Quintos B. Tung 2005 The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study Pediatrics 116 15 23 10.1542/peds.2004-1413 15995025
27. J. A. Haller H. Qin R. S. Apte R. R. Beck N. M. Bressler D. J. Browning R. P. Danis A. R. Glassman J. M. Googe C. Kollman A. K. Lauer M. A. Peters M. E. Stockman 2010 Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction Ophthalmology 117 1087 1093 e3 10.1016/j.ophtha.2010.03. 032 20299105
28. G. Heidary D. Vanderveen L. E. Smith 2009 Retinopathy of prematurity: current concepts in molecular pathogenesis Semin. Ophthalmol. 24 77 81 10.1080/08820530902800314 19373690
29. C. Hellberg A. Ostman C. H. Heldin 2010 PDGF and vessel maturation Recent Results Cancer Res. 180 103 114 1:CAS:528:DC%2BC3cXovVCqsr4%3D 10.1007/978-3-540-78281-0-7 20033380
30. A. Hellstrom C. Perruzzi M. Ju E. Engstrom A. L. Hard J. L. Liu K. Albertsson-Wikland B. Carlsson A. Niklasson L. Sjodell D. Leroith D. R. Senger L. E. Smith 2001 Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity Proc. Natl. Acad. Sci. U.S.A. 98 5804 5808 1:CAS:528:DC%2BD3MXjs1Wntro%3D 10.1073/pnas.101113998 11331770
31. G. B. Hubbard 3rd 2008 Surgical management of retinopathy of prematurity Curr. Opin. Ophthalmol. 19 384 390 10.1097/ICU.0b013e328309f1a5 18772670
32. R. D. Jager W. F. Mieler J. W. Miller 2008 Age-related macular degeneration N. Engl. J. Med. 358 2606 2617 1:CAS:528:DC%2BD1cXnt1WmtLc%3D 10.1056/NEJMra0801537 18550876
33. A. M. Joussen S. Doehmen M. L. Le K. Koizumi S. Radetzky T. U. Krohne V. Poulaki I. Semkova N. Kociok 2009 TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations Mol. Vis. 15 1418 1428 1:CAS:528: DC%2BD1MXhtVShtr%2FO 19641635
34. Y. J. Jung J. S. Isaacs S. Lee J. Trepel L. Neckers 2003 IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J. 17 2115 2117 1:CAS:528:DC%2BD3sXovFOhsb0%3D 12958148
35. P. K. Kaiser 2009 Vascular endothelial growth factor Trap-Eye for diabetic macular oedema Br. J. Ophthalmol. 93 135 136 10.1136/bjo.2008.144071 19174397
36. J. H. Kempen B. J. O'Colmain M. C. Leske S. M. Haffner R. KleIn S. E. Moss H. R. Taylor R. F. Hamman 2004 The prevalence of diabetic retinopathy among adults in the United States Arch. Ophthalmol. 122 552 563 10.1001/archopht.122. 4.552 15078674
37. J. H. Kim S. I. Khwarg H. K. Choung Y. S. Yu 2004 Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation Ophthalmic Surg. Lasers Imaging 35 446 452 15580966
38. J. H. Kim J. A. Park S. W. Lee W. J. Kim Y. S. Yu K. W. Kim 2006 Blood-neural barrier: intercellular communication at glio-vascular interface J. Biochem. Mol. Biol. 39 339 345 1:CAS:528:DC%2BD28Xotlygs74%3D 16889675
39. J. H. Kim Y. S. Yu J. Y. Shin H. Y. Lee K. W. Kim 2008 Deguelin inhibits retinal neovascularization by downregulation of HIF-1alpha in oxygen-induced retinopathy J. Cell. Mol. Med. 12 2407 2415 1:CAS:528:DC%2BD1MXht1Whur4%3D 10.1111/j.1582-4934.2008.00243.x 18208562
40. J. H. Kim Y. M. Lee E. M. Ahn K. W. Kim Y. S. Yu 2009 Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation J. Cereb. Blood Flow Metab. 29 1559 1567 1:CAS:528:DC%2BD1MXhtVKnurrJ 10.1038/jcbfm.2009.78 19536074
41. J. H. Kim M. Oh Y. S. Yu K. W. Kim H. J. Kwon 2009 N-hydroxy-7-(2- naphthylthio) heptanomide inhibits retinal and choroidal angiogenesis Mol. Pharm. 6 513 519 1:CAS:528:DC%2BD1MXhtlegtLg%3D 10.1021/mp800178b 19718802
42. J. H. Kim H. O. Jun Y. S. Yu K. W. Kim 2010 Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy Am. J. Pathol. 176 1517 1524 1:CAS:528:DC%2BC3cXktVOitr8%3D 10.2353/ajpath.2010. 090398 20110406
43. M. S. Kim H. J. Kwon Y. M. Lee J. H. Baek J. E. Jang S. W. Lee E. J. Moon H. S. Kim S. K. Lee H. Y. Chung C. W. Kim K. W. Kim 2001 Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes Nat. Med. 7 437 443 10.1038/86507 11283670
44. R. Klein T. Peto A. Bird M. R. Vannewkirk 2004 The epidemiology of age-related macular degeneration Am. J. Ophthalmol. 137 486 495 10.1016/j.ajo.2003.11.069 15013873
45. M. Kliffen H. S. Sharma C. M. Mooy S. Kerkvliet P. T. De Jong 1997 Increased expression of angiogenic growth factors in age-related maculopathy Br. J. Ophthalmol. 81 154 162 1:STN:280:DyaK2s3ht1eqtA%3D%3D 10.1136/bjo.81.2.154 9059252
46. A. Kvanta B. Steen S. Seregard 1996 Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma Exp. Eye Res. 63 511 518 1:CAS:528:DyaK28XnsFKnsb4%3D 10.1006/exer.1996.0141 8994354
47. S. Y. Lee D. K. Kim J. H. Cho J. Y. Koh Y. H. Yoon 2008 Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma Arch. Ophthalmol. 126 953 958 1:CAS:528:DC%2BD1cXptFymu7o%3D 10.1001/archopht.126.7. 953 18625942
48. P. Lin J. M. O'Brien 2009 Frontiers in the management of retinoblastoma Am. J. Ophthalmol. 148 192 198 1:CAS:528:DC%2BD1MXos12ksb4%3D 10.1016/j.ajo.2009.04.004 19477707
49. P. F. Lopez B. D. Sippy H. M. Lambert A. B. Thach D. R. Hinton 1996 Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes Invest. Ophthalmol. Vis. Sci. 37 855 868 1:STN:280:DyaK287otFCnsQ%3D%3D 8603870
50. I. S. Mantagos D. K. Vanderveen L. E. Smith 2009 Emerging treatments for retinopathy of prematurity Semin. Ophthalmol. 24 82 86 10.1080/08820530902800322 19373691
51. H. A. Mintz-Hittner 2010 Avastin as monotherapy for retinopathy of prematurity J. AAPOS 14 2 3 10.1016/j.jaapos.2009.12.002 20227612
52. N. Miyamoto Y. De Kozak N. Normand Y. Courtois J. C. Jeanny D. Benezra F. Behar-Cohen 2008 PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema Ophthalmic Res. 40 203 207 1:CAS:528:DC%2BD1cXkvVSms78%3D 10.1159/000119877 18421240
53. S. A. Mousa S. S. Mousa 2010 Current status of vascular endothelial growth factor inhibition in age-related macular degeneration BioDrugs 24 183 194 1:CAS:528:DC%2BC3cXos1Sisbw%3D 10.2165/11318550-000000000-00000 20210371
54. Z. Ni P. Hui 2009 Emerging pharmacologic therapies for wet age-related macular degeneration Ophthalmologica 223 401 410 1:CAS:528:DC%2BD1MXhtlSjsbfN 10.1159/000228926 19622904
55. S. H. Oh J. K. Woo Y. D. Yazici J. N. Myers W. Y. Kim Q. Jin S. S. Hong H. J. Park Y. G. Suh K. W. Kim W. K. Hong H. Y. Lee 2007 Structural basis for depletion of heat shock protein 90 client proteins by deguelin J. Natl. Cancer Inst. 99 949 961 1:CAS:528:DC%2BD2sXosVaqtrY%3D 10.1093/jnci/djm007 17565155
56. A. Ozkiris 2010 Anti-VEGF agents for age-related macular degeneration Expert Opin. Ther. Pat. 20 103 118 10.1517/13543770902762885 20021287
57. E. A. Palmer J. T. Flynn R. J. Hardy D. L. Phelps C. L. Phillips D. B. Schaffer B. Tung 1991 Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group Ophthalmology 98 1628 1640 1:STN:280:DyaK387psFGksA%3D%3D 1800923
58. J. S. Penn A. Madan R. B. Caldwell M. Bartoli R. W. Caldwell M. E. Hartnett 2008 Vascular endothelial growth factor in eye disease Prog. Retin. Eye Res. 27 331 371 1:CAS:528:DC%2BD1cXps1Giu7w%3D 10.1016/j.preteyeres.2008.05.001 18653375
59. Y. PIna H. Boutrid A. Schefler S. Dubovy W. Feuer M. E. Jockovich T. G. Murray 2009 Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment Invest. Ophthalmol. Vis. Sci. 50 1020 1024 10.1167/iovs.08-2654 18952925
60. C. W. Pugh P. J. Ratcliffe 2003 Regulation of angiogenesis by hypoxia: role of the HIF system Nat. Med. 9 677 684 1:CAS:528:DC%2BD3sXktFOnur8%3D 10.1038/nm0603-677 12778166
61. P. A. Quiram A. Capone Jr. 2007 Current understanding and management of retinopathy of prematurity Curr. Opin. Ophthalmol. 18 228 234 10.1097/ICU.0b013e3281107fd3 17435431
62. M. X. Repka B. Tung W. V. Good M. Shapiro A. Capone Jr. J. D. Baker C. C. Barr D. L. Phelps W. A. Van Heuven 2006 Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP) Arch. Ophthalmol. 124 24 30 10.1001/archopht.124.1.24 16401781
63. A. D. Ricart A. W. Tolcher G. Liu K. Holen G. Schwartz M. Albertini G. Weiss S. Yazji C. Ng G. Wilding 2008 Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study Clin. Cancer Res. 14 7924 7929 1:CAS:528: DC%2BD1cXhsVegt7%2FN 10.1158/1078-0432.CCR-08-0378 19047123
64. E. Rishi P. Rishi D. Ratra M. Bhende 2009 Off-label use of bevacizumab in retinopathy of prematurity Retina 29 284 10.1097/IAE.0b013e31818a1ee7 18854784
65. P. Sapieha D. Hamel Z. Shao J. C. Rivera K. Zaniolo J. S. Joyal S. Chemtob 2010 Proliferative retinopathies: angiogenesis that blinds Int. J. Biochem. Cell Biol. 42 5 12 1:CAS:528:DC%2BD1MXhsV2mt7zF 10.1016/j.biocel.2009. 10.006 19836461
66. T. Sato S. Kusaka H. Shimojo T. Fujikado 2009 Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity Ophthalmology 116 2165 2169 10.1016/j.ophtha.2009.04.026 19700197
67. C. J. Schofield P. J. Ratcliffe 2004 Oxygen sensing by HIF hydroxylases Nat. Rev. Mol. Cell Biol. 5 343 354 1:CAS:528:DC%2BD2cXjsFSltL8%3D 10.1038/nrm1366 15122348
68. P. P. Sfikakis N. Markomichelakis G. P. Theodossiadis V. Grigoropoulos N. Katsilambros P. G. Theodossiadis 2005 Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab Diabetes Care 28 445 447 10.2337/diacare.28.2. 445 15677814
69. J. Shen R. Samul R. L. Silva H. Akiyama H. Liu Y. Saishin S. F. Hackett S. Zinnen K. Kossen K. Fosnaugh C. Vargeese A. Gomez K. Bouhana R. Aitchison P. Pavco P. A. Campochiaro 2006 Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1 Gene Ther. 13 225 234 1:CAS:528: DC%2BD28Xmtlylsg%3D%3D 10.1038/sj.gt.3302641 16195704
70. C. L. Shields J. A. Shields K. A. Baez J. Cater P. V. De Potter 1993 Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors Br. J. Ophthalmol. 77 544 548 1:STN:280:DyaK2c%2Fjt1SktA%3D%3D 10.1136/bjo.77.9.544 8218048
71. C. L. Shields J. A. Shields K. Baez J. R. Cater P. De Potter 1994 Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors Cancer 73 692 698 1:STN:280:DyaK2c7jtVantA%3D%3D 10.1002/1097-0142(19940201)73: 3<692::AID-CNCR2820730331>3.0.CO;2-8 8299091
72. Singerman, L., Combination therapy using the small interfering RNA bevasiranib. Retina, 29, S49-S50 (2009).
73. J. S. Slakter 2006 Anecortave acetate for treating or preventing choroidal neovascularization Ophthalmol. Clin. North Am. 19 373 380 16935212
74. W. E. Smiddy H. W. Flynn Jr. 1999 Vitrectomy in the management of diabetic retinopathy Surv. Ophthalmol. 43 491 507 1:STN:280:DyaK1MzktlWrsw%3D%3D 10.1016/S0039-6257(99)00036-3 10416792
75. A. W. Stitt D. A. Simpson C. Boocock T. A. Gardiner G. M. Murphy D. B. Archer 1998 Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours J. Pathol. 186 306 312 1:STN:280:DyaK1M3islGltQ%3D%3D 10.1002/(SICI)1096-9896(1998110)186:3<306:: AID-PATH183>3.0.CO;2-B 10211121
76. J. M. Thurman B. Renner K. Kunchithapautham V. P. Ferreira M. K. Pangburn Z. Ablonczy S. Tomlinson V. M. Holers B. Rohrer 2009 Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury J. Biol. Chem. 284 16939 16947 1:CAS:528:DC%2BD1MXntFCjtrw%3D 10.1074/jbc. M808166200 19386604
77. N. Tian 2004 Visual experience and maturation of retinal synaptic pathways Vision Res. 44 3307 3316 10.1016/j.visres.2004.07.041 15535998
78. M. J. Tolentino 2009 Current molecular understanding and future treatment strategies for pathologic ocular neovascularization Curr. Mol. Med. 9 973 981 1:CAS:528:DC%2BD1MXhsFGqtLzN 10.2174/156652409789712783 19925410
79. S. M. Weis D. A. Cheresh 2005 Pathophysiological consequences of VEGF-induced vascular permeability Nature 437 497 504 1:CAS:528: DC%2BD2MXhtVajs7vM 10.1038/nature03987 16177780
80. G. Zahn D. Vossmeyer R. Stragies M. Wills C. G. Wong K. U. Loffler A. P. Adamis J. Knolle 2009 Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization Arch. Ophthalmol. 127 1329 1335 1:CAS:528:DC%2BD1MXhtlGntrzL 10.1001/archophthalmol.2009.265 19822850